Actively Recruiting
Observational Study of Radiotherapy-Sensitized Immunotherapy Safety and Effectiveness in Advanced Breast Cancer
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2026-06-09
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and effectiveness of radiotherapy-sensitized immunotherapy in patients with advanced breast cancer that is inoperable or has spread to other parts of the body. This observational study is conducted at multiple centers and aims to better understand how immunotherapy combined with radiotherapy works for these patients. Participants who have already received or are planned to receive immunotherapy and have completed radiotherapy after evaluation by a multidisciplinary team will be registered and followed. They will continue systemic treatment including immunotherapy as chosen by their doctors. The study observes these treatments without assigning participants to specific interventions. During the study, participants will be followed over time with their medical history tracked and monitored. Researchers will measure progression-free survival over 24 months to see how long patients live without their cancer worsening. The total duration of participation may vary depending on individual treatment and follow-up plans.
CONDITIONS
Brief Title
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
Research Team
F
Fei Ma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
